Crystal deposition joint disease.
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000378:metabolism; D002805:Chondrocalcinosis / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D003078:Colchicine / Q000627:therapeutic use; D003460:Crystallization; D011756:Diphosphates / Q000032:analysis / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D005260:Female; D006073:Gout / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007592:Joint Diseases / Q000378:metabolism; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013582:Synovial Fluid / Q000032:analysis; D014527:Uric Acid / Q000378:metabolism; D014961:X-Ray Diffraction
D011756:Diphosphates; D014527:Uric Acid; D010653:Phenylbutazone; D011339:Probenecid; D003078:Colchicine; D013442:Sulfinpyrazone; D007213:Indomethacin